BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 22822074)

  • 21. Death by deamination: a novel host restriction system for HIV-1.
    Goff SP
    Cell; 2003 Aug; 114(3):281-3. PubMed ID: 12914693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A biochemical analysis linking APOBEC3A to disparate HIV-1 restriction and skin cancer.
    Pham P; Landolph A; Mendez C; Li N; Goodman MF
    J Biol Chem; 2013 Oct; 288(41):29294-304. PubMed ID: 23979356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA.
    Russell RA; Moore MD; Hu WS; Pathak VK
    Retrovirology; 2009 Feb; 6():16. PubMed ID: 19216784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms.
    Thielen BK; McNevin JP; McElrath MJ; Hunt BV; Klein KC; Lingappa JR
    J Biol Chem; 2010 Sep; 285(36):27753-66. PubMed ID: 20615867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
    Suspène R; Sommer P; Henry M; Ferris S; Guétard D; Pochet S; Chester A; Navaratnam N; Wain-Hobson S; Vartanian JP
    Nucleic Acids Res; 2004; 32(8):2421-9. PubMed ID: 15121899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Competition for DNA binding between the genome protector replication protein A and the genome modifying APOBEC3 single-stranded DNA deaminases.
    Wong L; Sami A; Chelico L
    Nucleic Acids Res; 2022 Nov; 50(21):12039-12057. PubMed ID: 36444883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA.
    Kitamura K; Wang Z; Chowdhury S; Simadu M; Koura M; Muramatsu M
    PLoS Pathog; 2013; 9(5):e1003361. PubMed ID: 23696735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.
    Schumacher AJ; Haché G; Macduff DA; Brown WL; Harris RS
    J Virol; 2008 Mar; 82(6):2652-60. PubMed ID: 18184715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo.
    Liddament MT; Brown WL; Schumacher AJ; Harris RS
    Curr Biol; 2004 Aug; 14(15):1385-91. PubMed ID: 15296757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient deamination of 5-methylcytidine and 5-substituted cytidine residues in DNA by human APOBEC3A cytidine deaminase.
    Suspène R; Aynaud MM; Vartanian JP; Wain-Hobson S
    PLoS One; 2013; 8(6):e63461. PubMed ID: 23840298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
    Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities.
    Langlois MA; Beale RC; Conticello SG; Neuberger MS
    Nucleic Acids Res; 2005; 33(6):1913-23. PubMed ID: 15809227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action.
    Santa-Marta M; Aires da Silva F; Fonseca AM; Rato S; Goncalves J
    Mol Immunol; 2007 Jan; 44(4):583-90. PubMed ID: 16580072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-Angle X-ray Scattering (SAXS) Measurements of APOBEC3G Provide Structural Basis for Binding of Single-Stranded DNA and Processivity.
    Barzak FM; Ryan TM; Mohammadzadeh N; Harjes S; Kvach MV; Kurup HM; Krause KL; Chelico L; Filichev VV; Harjes E; Jameson GB
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An overview of cytidine deaminases.
    Navaratnam N; Sarwar R
    Int J Hematol; 2006 Apr; 83(3):195-200. PubMed ID: 16720547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
    Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
    J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human-APOBEC3G-dependent restriction of porcine endogenous retrovirus replication is mediated by cytidine deamination and inhibition of DNA strand transfer during reverse transcription.
    Jin SY; Choi HY; Kim HS; Jung YT
    Arch Virol; 2018 Jul; 163(7):1907-1914. PubMed ID: 29610985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase.
    Nowarski R; Britan-Rosich E; Shiloach T; Kotler M
    Nat Struct Mol Biol; 2008 Oct; 15(10):1059-66. PubMed ID: 18820687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
    Luo K; Wang T; Liu B; Tian C; Xiao Z; Kappes J; Yu XF
    J Virol; 2007 Jul; 81(13):7238-48. PubMed ID: 17428847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.
    Kobayashi T; Koizumi Y; Takeuchi JS; Misawa N; Kimura Y; Morita S; Aihara K; Koyanagi Y; Iwami S; Sato K
    J Virol; 2014 May; 88(10):5881-7. PubMed ID: 24623435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.